Multiomics Approach in Adult Patients With Phenylketonuria
ConditionPhenylketonuria (PKU)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Tours
About this trial
The GENOPHEN study aims to explore the links between the genome, metabolomic profile, and clinical phenotype in adults with early-treated PKU.
Eligibility criteria
Qualifiers
PKU patients over the age of 18,
diagnosed through the newborn screening program,
patients who participated in the final visit of the ECOPHEN study,
affiliation with a health insurance plan,
Disqualifiers
Patients whose PKU diagnosis was not detected during neonatal screening,
Patients who have not signed a dated informed consent form,
Patients who are unable to provide a saliva sample.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov